⚡ Key Takeaways
- Standard 5-tier formulary: Tier 1 generic, Tier 2 non-preferred generic, Tier 3 preferred brand, Tier 4 non-preferred brand, Tier 5 specialty
- Commercial Tier 1 copays typically $0–$15; Tier 5 specialty uses 25–40% coinsurance often capped at $1,000–$1,500/month
- Medicare Part D 2026 annual out-of-pocket cap is $2,000 — transformational consumer protection from IRA
- Insulin capped at $35/month on every Medicare Part D plan in 2026
- Prior authorization required on 25–35% of specialty drugs; step therapy on many high-tier prescriptions
- Connecticut state law CGS §38a-510a provides robust step therapy exception protections
- Same drug can sit on different tiers at different CT carriers — annual savings of $3,000+ from picking right plan
- Anthem CT uses CarelonRx; ConnectiCare uses Express Scripts; CTCare Benefits uses CVS Caremark — three different formularies
- Manufacturer copay cards usable on commercial plans (not Medicare); foundation grants for Medicare patients
- Medicare Prescription Payment Plan lets beneficiaries spread $2,000 cap across 12 monthly installments
Key Takeaways
Why Drug Tiers Matter More Than You Think
What a Formulary Actually Is
Sources: CT Insurance Department Drug Coverage Resources
The Standard 5-Tier Structure (2026)
Standard 2026 Formulary Tier Structure
| Tier | Drug Category | Typical Copay (Commercial) | Typical Cost-Share (Medicare Part D) |
|---|---|---|---|
| Tier 1 | Preferred generics | $0–$15 | $0–$10 |
| Tier 2 | Non-preferred generics & preferred brand-name generics | $15–$50 | $5–$25 |
| Tier 3 | Preferred brand-name | $45–$110 | $40–$92 |
| Tier 4 | Non-preferred brand-name | $85–$300 or 30–50% coinsurance | $95–$200 or 40–50% coinsurance |
| Tier 5 | Specialty drugs (biologics, injectables, oncology) | 25–40% coinsurance, sometimes capped at $1,000–$1,500/month | 25–33% coinsurance to $2,000 annual cap |
| Tier 6 (some plans) | Select care specialty (oral oncology, MS, RA) | Negotiated coinsurance with cap | Capped within $2,000 annual |
Commercial (Access Health CT + Employer) Tier Costs for 2026
2026 Access Health CT Silver Plan Rx Costs (Typical)
| Tier | After Deductible? | Anthem CT HMO Silver | ConnectiCare Silver | CTCare Benefits Silver |
|---|---|---|---|---|
| Tier 1 (generic) | No (waived) | $10 | $5 | $10 |
| Tier 2 (preferred generic) | No (waived) | $30 | $25 | $30 |
| Tier 3 (preferred brand) | Yes | $60 | $60 | $70 |
| Tier 4 (non-preferred brand) | Yes | 30% coinsurance | 35% coinsurance | 30% coinsurance |
| Tier 5 (specialty) | Yes | 30% coinsurance (max $1,000/mo) | 30% coinsurance (max $1,200/mo) | 35% coinsurance |
| Mail-order 90-day (Tier 1–3) | Yes per tier | 2x retail copay | 2x retail copay | 2x retail copay |
| Preventive drugs (statins, contraceptives, smoking cessation) | $0 per ACA | $0 | $0 | $0 |
Sources: HealthCare.gov Preventive Drug List
Medicare Part D Tier Costs and the IRA $2,000 Cap
2026 Medicare Part D Standard Benefit Structure
| Phase | Trigger | Member Cost | Plan Cost |
|---|---|---|---|
| Deductible phase | $0 spent (up to $590 deductible) | 100% (up to $590) | 0% |
| Initial coverage | $590–$5,030 total drug cost (TrOOP $0–$2,000) | Tiered copay/coinsurance per plan | Balance |
| Catastrophic phase | Member out-of-pocket reaches $2,000 | $0 — IRA cap eliminates all further cost-sharing | 100% |
| Insulin (any phase) | Any qualifying insulin product | $35/month cap (any phase) | Balance |
Sources: CMS Part D 2026 Standard Benefit
Specialty Drugs (Tier 4 & 5) — Where the Money Is
Common Specialty Drug Categories on Connecticut Formularies
- Autoimmune biologics: Humira (adalimumab — now with biosimilar competition), Enbrel, Stelara, Cosentyx, Skyrizi, Rinvoq, Dupixent
- MS drugs: Ocrevus, Kesimpta, Tysabri, Tecfidera, Aubagio
- Oncology orals: Ibrance, Verzenio, Imbruvica, Tagrisso, Enhertu
- GLP-1 weight loss / diabetes: Ozempic, Wegovy, Mounjaro, Zepbound
- Hepatitis C cures: Mavyret, Epclusa, Vosevi
- HIV: Biktarvy, Triumeq, Descovy (PrEP), Cabenuva (long-acting injectable)
- Cystic fibrosis: Trikafta
- PCSK9 inhibitors: Repatha, Praluent
- Migraine prevention CGRPs: Aimovig, Ajovy, Emgality, Vyepti, Nurtec, Qulipta
- Rare disease enzyme replacements: Cerezyme, Elaprase, Soliris
Prior Authorization — What It Is and How to Get Past It
What
- Patient
- FDA-approved indication match (or documented medical necessity for off-label)
- Documentation that step therapy/lower-cost alternatives have been tried (if applicable)
- Lab results, imaging, or specialist evaluation supporting the prescription
- Prescriber
- Treatment duration and dose justification
- Failed therapies and adverse reactions to alternatives
- Sometimes patient sign-off on a chronic condition management plan
Sources: CT Insurance Department Appeals Process
The PA Surprise
Step Therapy — The
Documenting a Step Therapy Exception
- Prior trial of required drugs (medication name, dose, duration, outcome)
- Documented adverse effects or treatment failure with required drugs
- Specialist letter explaining clinical rationale for requested drug
- Lab data, imaging, or symptom diaries supporting necessity
- If switching from prior coverage: documentation of stability on requested drug
- ICD-10 diagnoses justifying the more expensive medication
Quantity Limits and Day Supplies
Generic vs Brand vs Biosimilar — The Real Differences
Common 2026 Connecticut Generic Substitutions
- Lipitor → atorvastatin (Tier 1)
- Crestor → rosuvastatin (Tier 1)
- Plavix → clopidogrel (Tier 1)
- Synthroid → levothyroxine (Tier 1)
- Lexapro → escitalopram (Tier 1)
- Cymbalta → duloxetine (Tier 2 generic)
- Advair → fluticasone/salmeterol (Tier 2 or AB-rated generic)
- Humira → adalimumab-aacf, adalimumab-bwwd, etc. (Tier 5 preferred specialty)
- Enbrel → currently no FDA-approved biosimilar substitution (still Tier 5 brand)
- Lantus → insulin glargine (Tier 2 — IRA $35 cap)
Mail Order, 90-Day Fills, and Pharmacy Networks
Pharmacy Network Tiers (Typical 2026 CT)
- Preferred retail: large chains (CVS, Walgreens, Stop & Shop, Big Y, ShopRite, Costco) at lowest copay
- Standard retail: independent pharmacies, smaller chains at higher copay
- Out-of-network: very few CT plans cover out-of-network pharmacies — verify before assuming
- Mail-order: 90-day supply at 2x retail copay (one month free per quarter)
- Specialty pharmacy: required for Tier 5 drugs; insurer designates the pharmacy
Formulary Exclusions and How to Appeal
Sources: CT Insurance Department External Review
What Connecticut Carriers Use in 2026
2026 Connecticut Carrier PBMs and Formulary Notes
| Carrier | PBM | Formulary | Specialty Pharmacy |
|---|---|---|---|
| Anthem CT | CarelonRx (in-house) | Anthem National Drug List | CarelonRx Specialty |
| ConnectiCare | Express Scripts | ConnectiCare Custom Formulary | Accredo |
| CTCare Benefits | CVS Caremark | Custom Connecticut Formulary | CVS Specialty |
| Cigna (off-exchange) | Express Scripts (Cigna-owned) | Cigna Standard or Performance | Accredo |
| UnitedHealthcare (Medicare + employer) | OptumRx | UHC Premium / Advantage / Traditional | OptumRx Specialty |
| Aetna (Medicare + employer) | CVS Caremark (CVS-owned) | Aetna Standard Opt Out | CVS Specialty |
Six Real Connecticut Prescription Scenarios
How Drug Costs Interact With Your MOOP
Sources: Out-of-pocket maximum guide (CT 2026)
Manufacturer Assistance and Copay Cards
- Copay cards (commercial insurance only) — bring branded drug copay down to $0–$25/month. Examples: Humira Complete Savings Card, Eliquis 360 Support, Ozempic Savings Card. NOT usable with Medicare or Medicaid by federal law.
- Patient Assistance Programs (PAPs) — free drug supply for uninsured or underinsured patients meeting income thresholds. Common across Lilly, Pfizer, Bristol-Myers Squibb, Novo Nordisk, Sanofi.
- Foundation-based copay assistance (Medicare & commercial) — independent foundations (PAN, HealthWell, Good Days, ALSO Foundation) provide copay grants for specific disease states. Critical for Medicare beneficiaries who can
- State pharmacy assistance: Connecticut
Drug-Tier Shopping Checklist Before Enrolling
- List EVERY prescription you currently take (drug name, strength, frequency, prescriber)
- Note any anticipated new prescriptions (planned surgery, chronic disease diagnosis, GLP-1 starting)
- Look up each drug on every plan
- Note the tier and any restrictions (PA, step therapy, quantity limit) for each drug
- Calculate annual cost: per-fill copay × number of fills (most chronic drugs = 12 fills/year)
- Verify your pharmacy is in the carrier
- Check if specialty drugs require a specific specialty pharmacy
- Confirm whether the carrier covers your drug at 90-day mail-order
- Verify if any drug is on the ACA $0 preventive list (statins, contraceptives, etc.)
- For Medicare: confirm the drug is on the Part D formulary tier you expect
- If you anticipate hitting the Part D $2,000 cap, enroll in the Medicare Prescription Payment Plan
Drug Coverage Mistakes Connecticut Patients Make
- Picking a plan on premium alone without checking the formulary for chronic medications
- Assuming the same drug stays on the same tier when switching carriers — formularies vary wildly
- Not requesting a 90-day mail-order fill — leaving $100–$400/year on the table per chronic drug
- Letting a prior authorization lapse during a January 1 plan switch — pre-submit PAs in late December
- Not knowing about Connecticut
- Failing to enroll in manufacturer copay cards on branded drugs — paying $200/month when $10/month is available
- Medicare beneficiaries assuming their old Part D plan stays best each year — re-shop annually during AEP
- Not enrolling in the Medicare Prescription Payment Plan when expecting $2,000+ in annual drug costs
- Assuming weight-loss GLP-1s are covered — most CT commercial plans require BMI + comorbidity documentation; Medicare doesn
- Filling specialty drugs at retail pharmacies — insurers redirect to a specialty pharmacy and may not pay retail
- Switching between branded and biosimilar without prescriber coordination — minor differences in injection devices and inactive ingredients can matter
How We Find Your Insurance Helps Connecticut Patients With Drug Coverage
Sources: Medicare Part D guide (CT 2026), Health insurance broker near me (CT 2026)
Schedule a Free Drug-Tier Review
Frequently Asked Questions
Frequently Asked Questions
How do prescription drug tiers work?
Drug tiers classify prescriptions by cost and clinical preference. Tier 1 generics cost $0–$15. Tier 2 generics cost $15–$50. Tier 3 preferred brand costs $45–$110. Tier 4 non-preferred brand uses 30–50% coinsurance. Tier 5 specialty drugs use 25–40% coinsurance (often capped). The same drug can sit on different tiers at different carriers.
Does my prescription cost count toward my out-of-pocket maximum?
On commercial plans yes — every dollar you pay for in-network covered prescriptions counts toward the federal MOOP. On Medicare Part D, drug costs are capped separately at $2,000/year under the Inflation Reduction Act starting in 2025 and continuing in 2026.
What is prior authorization for a prescription drug?
Prior authorization is the insurer’s required approval before paying for certain drugs. About 25–35% of specialty drugs and 10–15% of brand-name Tier 3/4 drugs require PA in Connecticut. Electronic prior auth portals (CoverMyMeds) resolve in hours; emergency expedited PAs in 24 hours.
What is step therapy?
Step therapy requires you to try lower-cost alternative drugs before the insurer pays for a more expensive one. Connecticut law CGS §38a-510a allows exceptions when the required drug is contraindicated, has caused adverse reactions, has failed, or when you’re stable on the requested drug from prior coverage.
What
$2,000. The Inflation Reduction Act capped annual prescription costs at $2,000 per Medicare Part D beneficiary, with no further coinsurance after the cap is met. Insulin is capped at $35/month across all Part D plans.
Does Medicare cover Ozempic, Wegovy, Mounjaro, or Zepbound?
Medicare covers Ozempic and Mounjaro when prescribed for Type 2 diabetes. Wegovy and Zepbound for weight loss alone are not covered by Medicare — federal law prohibits Part D coverage of weight-loss drugs.
Can I use a manufacturer copay card with Medicare?
No. Federal law prohibits manufacturer copay cards from being used by Medicare or Medicaid beneficiaries. Medicare patients can use foundation-based copay assistance programs (PAN Foundation, HealthWell, Good Days) instead.
What happens to my prior authorization if I switch plans on January 1?
It does not transfer. Every prior authorization must be re-issued on the new plan. Stockpile a 90-day refill on the old plan before switching and have your prescriber pre-submit PAs to the new carrier in December to avoid January gaps.
What
Humira (adalimumab) is the branded reference biologic. Biosimilars (Hadlima, Amjevita, Cyltezo, etc.) are FDA-approved ‘highly similar’ versions costing 30–60% less. Most Connecticut carriers now prefer biosimilars on Tier 5 specialty and have moved branded Humira to non-preferred.
How do I find a Connecticut broker to run a drug-tier review?
Call We Find Your Insurance at (860) 856-5894. Licensed agent Antonucci, Joseph (CT #21658409) runs every drug on your list against every carrier’s 2026 formulary at no cost to the consumer.